Coding, modifier, and regulatory effects shape circulating APOL1 levels
Walt E Adamson, Harry Noyes, John Ogunsola, Rulan S Parekh, Anneli Cooper, Annette MacLeod · 2026
Read Coding, modifier, and regulatory effects shape circulating APOL1 levels by Walt E Adamson, Harry Noyes, John Ogunsola, Rulan S Parekh, Anneli Cooper, Annette MacLeod (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13626210.txt.
Description
Walt Adamson and co-authors present a 2026 study of what sets the level of a protein in blood that is tied to kidney disease risk. Variants of this protein's gene are major risk factors for chronic kidney disease in people with recent African ancestry. Yet how gene type and nearby control variants shape the protein's blood level was not well defined.
The team measured the protein in over forty thousand UK Biobank members. Levels varied in a dose-like way with known gene variants, one of which had the largest effect. Even after gene type was counted, levels stayed higher in Black participants. The study maps coding, modifier, and regulatory effects on the protein.
Catalog record
| CREATOR | Walt E Adamson, Harry Noyes, John Ogunsola, Rulan S Parekh, Anneli Cooper, Annette MacLeod |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |